About Fauna Bio
Fauna Bio is a Healthcare company based in Berkeley (United States) founded in 2018 by Ashley Zehnder, Linda Goodman, and Katie Grabek. It operates as an animal genomics is applied to healthcare advancements by Fauna Bio. Fauna Bio has raised $13.1 million across 7 funding rounds from investors including NIH, HHS and Lifeforce Capital. Its chief executive is Ashley Zehnder. Fauna Bio offers products and services including Convergence Platform. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is FAUNA BIO INCORPORATED. Its competitors include BeaconCure, Predxbio, Humaneva Group, Private Health Management and RegenMed and 1 more; 4 of its 6 listed competitors have raised funding.
Company details
Fauna Bio was founded in 2018 and is based in Berkeley, United States. Operations focus on the healthcare sector, with emphasis on animal genomics research. Services involve genomic analysis and applications derived from animal models to address human health challenges. The company is led by co-founders including Ashley Zehnder as CEO, Linda Goodman as CTO, and Katie Grabek as CSO, supporting advancements in biotechnology.
- Headquarters Berkeley, United States
- Founders Ashley Zehnder, Linda Goodman, Katie Grabek
- SectorsHealthcare
- Website faunabio.com
- Social LinkedIn X YouTube
- Legal Name Fauna Bio Incorporated
- Total Equity Funding$13.1M (USD)
in 7 rounds
- InvestorsNIH
& 11 more
Products & Services of Fauna Bio
Fauna Bio offers a comprehensive portfolio of products and services, including Convergence Platform.
AI tool for analyzing animal genetics to identify drug targets
Apps and channels of Fauna Bio
its YouTube channel Fauna Bio has 13 subscribers and 5 videos.
Videos from Fauna Bio
The most watched videos on Fauna Bio's YouTube channel, Fauna Bio (13 subscribers). Click a video to play it here.
More on Fauna Bio.
Funding Insights of Fauna Bio
Fauna Bio has successfully raised a total of $13.1M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.1M
- Total Rounds 7
- First Round $4.1M
(Apr 2019)
- Investors Count 12
All 7 funding rounds of Fauna Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | – | Seed | – | – | |
| Nov 2024 | $244,054 | Grant | – | – | |
| Sep 2021 | $9M | Seed | – | Lifeforce Capital | |
| Jun 2021 | $373,434 | Grant | – | – | |
| Feb 2021 | $550,712 | Grant | – | – | |
| Sep 2019 | $228,934 | Grant | – | – | |
| Apr 2019 | $4.1M | Seed | – | True Ventures |
12 investors in total: 12 institutional.
Investors in Fauna Bio
Fauna Bio has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Lifeforce Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on healthcare startups | – | lifeforcecap.com | San Francisco, United States | |
Venture capital firm supporting AI founders through investments and community. | – | trueventures.com | - | |
Early investments in science-focused startups are made by BOOM Capital. | – | boomcap.co | - | |
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe | – | biomedvc.com | Basel, Switzerland | |
Venture capital is provided for longevity-focused biotech startups. | 2011 | longevity.vc | - | |
- | – | beagleventures.cl | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Pacific 8 Ventures is focused on healthcare technology investments. | – | pac8.com | United States | |
- | – | arcadia.science | - | |
Business capital funding is offered by Vibe Capital. | – | vibecap.com | - |
Investor details for Fauna Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fauna Bio
12 people are tracked at Fauna Bio (6 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Ashley Zehnder | Co-Founder & CEO | Leadership |
Linda Goodman | Co-Founder & CTO | Leadership |
Katie Grabek | Co-Founder & CSO | Leadership |
Ben Sajdak | Director of Emerging Animal Models | Leadership |
Michael F. Geremia | Senior Vice President Finance & Operations | Leadership |
Bryan Burkey Ph.D. | Head, Therapeutics Discovery | Leadership |
Katharine Grabek | CSO | Team |
Manasvi Borad | Data Engineer | Team |
Carlos D. Bustamante | Scientific Advisor | Team |
Rui Song | Senior Research Scientist | Team |
Gennady Gorin | Senior Scientist, Computational Biology | Team |
Phil McNamara | Bioinformatics Platform Developer | Team |
Complete people profiles for Fauna Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fauna Bio
3 dated milestones of Fauna Bio across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Fauna Bio is founded.
- Funding First funding round of $4.1M.
- Funding Latest funding round, Seed,.
Competitors of Fauna Bio
Fauna Bio has 6 listed competitors in our database, 4 of them funded. They include BeaconCure, Predxbio, Humaneva Group, Private Health Management and RegenMed, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| humaneva.com | 2014 | Raleigh, United States | $50M | – | Provider of clinical research data services for oncology & other therapeutic areas | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. | |
| rgnmed.com | 2014 | Greenwich, United States | $290,000 | – | Healthcare data analytics company that enables clinical and financial value creation for clinicians | |
| pharmolix.com | 2023 | China | – | – | Biotechnology company that develops and commercializes AI-powered foundation models for the biomedical industry |
Detailed competitors of Fauna Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fauna Bio
The website of Fauna Bio (faunabio.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▼ 7.2% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Fauna Bio (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fauna Bio
Complete news archive for Fauna Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fauna Bio
Fauna Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Fauna Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Ashley Zehnder is the current CEO of Fauna Bio. They have also founded this company.
Fauna Bio is a funded company, having raised a total of $13.1M across 7 funding rounds to date. The company's 1st funding round was a Seed of $4.1M, raised on Apr 2019.
Fauna Bio was founded in 2018 and is based in Berkeley, United States. Operations focus on the healthcare sector, with emphasis on animal genomics research. Services involve genomic analysis and applications derived from animal models to address human health challenges. The company is led by co-founders including Ashley Zehnder as CEO, Linda Goodman as CTO, and Katie Grabek as CSO, supporting advancements in biotechnology.
Fauna Bio's top competitors include Predxbio, BeaconCure and RegenMed.
Fauna Bio offers Convergence Platform.
Fauna Bio has 12 investors. Key investors include NIH, HHS, Lifeforce Capital, True Ventures, and BOOM Capital.
Fauna Bio operates through Fauna Bio Incorporated.